Published in J Chem Soc Perkin 1 on January 01, 1973
Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health (1993) 11.92
An improved and simplified method of detecting the acetylator phenotype. J Med Genet (1969) 6.40
Natural history of mild cognitive impairment in older persons. Neurology (2002) 6.09
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology (2005) 5.76
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet (1980) 5.68
Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord (2001) 5.09
Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci (1991) 4.53
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob Agents Chemother (1986) 4.51
Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J (1969) 4.21
Latent Semantic Indexing of medical diagnoses using UMLS semantic structures. Proc Annu Symp Comput Appl Med Care (1991) 4.09
Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol (1993) 3.74
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology (2004) 3.61
Nomenclature for N-acetyltransferases. Pharmacogenetics (1995) 3.59
Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology (2003) 3.59
Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med (1996) 3.48
Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milano) (1993) 3.47
Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology (2002) 3.40
Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br (1982) 3.39
Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology (2003) 3.35
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc Natl Acad Sci U S A (1995) 3.18
Age-specific incidence of Alzheimer's disease in a community population. JAMA (1995) 3.09
Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med (1992) 2.92
Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett (2001) 2.86
Cognitive activity and incident AD in a population-based sample of older persons. Neurology (2002) 2.77
Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ (1990) 2.70
Depressive symptoms and cognitive decline in a community population of older persons. J Neurol Neurosurg Psychiatry (2004) 2.67
A prospective study of incident comprehensive medical home care use among the elderly. Am J Public Health (1988) 2.67
Social resources and cognitive decline in a population of older African Americans and whites. Neurology (2004) 2.66
Biosynthesis of vitamin B12: identity of fragment extruded during ring contraction to the corrin macrocycle. Proc Natl Acad Sci U S A (1981) 2.60
Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology (2003) 2.60
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. Antimicrob Agents Chemother (1997) 2.57
Change in body mass index and risk of incident Alzheimer disease. Neurology (2005) 2.48
Cognitive decline in incident Alzheimer disease in a community population. Neurology (2010) 2.41
Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology (2003) 2.32
Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci (1999) 2.31
Correlates of cognitive function in an elderly community population. Am J Epidemiol (1988) 2.26
ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease. Antimicrob Agents Chemother (1998) 2.23
Chiral bis(oxazoline) copper(II) complexes: versatile catalysts for enantioselective cycloaddition, Aldol, Michael, and carbonyl ene reactions. Acc Chem Res (2000) 2.22
Age of Neoproterozoic bilatarian body and trace fossils, White Sea, Russia: implications for metazoan evolution. Science (2000) 2.21
Terminal decline in cognitive function. Neurology (2003) 2.18
Cognitive activity and cognitive decline in a biracial community population. Neurology (2003) 2.06
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology (2008) 1.97
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler (2006) 1.95
Epidemiology of disability in the oldest old: methodologic issues and preliminary findings. Milbank Mem Fund Q Health Soc (1985) 1.94
Cadaveric study of movement of an unstable atlanto-axial (C1/C2) cervical segment during laryngoscopy and intubation using the Airtraq(®) , Macintosh and McCoy laryngoscopes. Anaesthesia (2014) 1.93
Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations. Pharmacogenetics (1997) 1.92
The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J Med Genet (1983) 1.92
Trypanosoma brucei: Miniature anion-exchange centrifugation technique for detection of low parasitaemias: Adaptation for field use. Trans R Soc Trop Med Hyg (1979) 1.92
Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol (1993) 1.91
Temporal course of depressive symptoms during the development of Alzheimer disease. Neurology (2010) 1.87
Biosynthesis of the pigments of life: formation of the macrocycle. Nature (1980) 1.86
Analysis of change in self-reported physical function among older persons in four population studies. Am J Epidemiol (1996) 1.86
The actylation of sulamethazine and sulfamethoxypyridazine by human subjects. Clin Pharmacol Ther (1968) 1.85
Sputum examination for the diagnosis of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 1.84
Cognitive decline after hospitalization in a community population of older persons. Neurology (2012) 1.83
Empirical, automated vocabulary discovery using large text corpora and advanced natural language processing tools. Proc AMIA Annu Fall Symp (1996) 1.81
Social networks and disability transitions across eight intervals of yearly data in the New Haven EPESE. J Gerontol B Psychol Sci Soc Sci (1999) 1.79
Educational attainment and cognitive decline in old age. Neurology (2009) 1.78
The polymorphic acetylation of sulphapyridine in man. J Med Genet (1972) 1.72
A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology (2003) 1.71
Risk factors for delirium in hospitalized elderly. JAMA (1992) 1.70
Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol (2001) 1.70
Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology (2005) 1.70
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects. Gut (1972) 1.70
Biosynthesis of porphyrins and related macrocycles. Part 10. Vitamin B12: biochemical derivation of cobyrinic acid from uroporphyrinogen III. Studies with corresponding ring c methyl heptacarboxylic prophyrinogen, and proof of seven intact methyl transfers. J Chem Soc Perkin 1 (1977) 1.69
Genetic control of nortriptyline kinetics in man: a study of relatives of propositi with high plasma concentrations. J Med Genet (1971) 1.66
Synthesis of antibacterial p-quinols from marine sponges. Synthetic applications of "masked" quinones. J Org Chem (1977) 1.65
Evaluation of spontaneous reports of adverse reactions to drugs. Br Med J (1972) 1.64
Traditional criteria as predictors of minority student success in medical school. J Med Educ (1975) 1.61
Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med (1990) 1.61
Genetic polymorphism and interethnic variability of plasma paroxonase activity. J Med Genet (1976) 1.61
Epidemiology of injury in people with Alzheimer's disease. J Am Geriatr Soc (1995) 1.58
Genetic control of phenylbutazone metabolism in man. Br Med J (1970) 1.58
Associations of vegetable and fruit consumption with age-related cognitive change. Neurology (2006) 1.57
Occurrence of Cryptosporidium oocysts in fecal samples submitted for routine microbiological examination. J Clin Microbiol (1985) 1.57
The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry (2002) 1.57
Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am J Med (1982) 1.56
Cognitive activity and the cognitive morbidity of Alzheimer disease. Neurology (2010) 1.56
The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. Stroke (2005) 1.55
Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology (2004) 1.53
Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study. Crit Care Med (2006) 1.52
Genetic variations in the acetylation of isoniazid and other drugs. Ann N Y Acad Sci (1968) 1.52
Six-year effect of depressive symptoms on the course of physical disability in community-living older adults. Arch Intern Med (2000) 1.49
Changes in oxidative metabolism and ultrastructure accompanying differentiation of the mitochondrion in Trypanosoma brucei. Int J Parasitol (1973) 1.48
Physicians declining patient enrollment in a critical care trial: a case study in thromboprophylaxis. Intensive Care Med (2013) 1.46
Plasma kinetics and urinary excretion of primaquine in man. Br J Clin Pharmacol (1980) 1.46
Biosynthesis of vitamin B12: structure of precorrin-6x octamethyl ester. Proc Natl Acad Sci U S A (1990) 1.46
Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol Aging (2000) 1.44
Body mass index and cognitive decline in a biracial community population. Neurology (2007) 1.44
ABO blood groups in gastric bleeding. Gut (1966) 1.44
Current and remote blood pressure and cognitive decline. JAMA (1999) 1.43
Propionate assimilation in the flagellate Polytomella caeca. An inducible mitochondrial enzyme system. Biochem J (1968) 1.41
Effects of Artemisia pallens Wall. on blood glucose levels in normal and alloxan-induced diabetic rats. J Ethnopharmacol (1996) 1.41
Oral acyclovir for chickenpox. Cutis (1991) 1.40
Fertility desires and fertility: hers, his, and theirs. Demography (1990) 1.40
Carcinoma of the colon associated with systemic sclerosis. N Y State J Med (1990) 1.39
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology (2008) 1.36
Evidence of genetic recombination in Leishmania. Mol Biochem Parasitol (1991) 1.32